{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:35:13Z","timestamp":1790174113588,"version":"4.1.0"},"reference-count":49,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"9","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["award341254"],"award-info":[{"award-number":["award341254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIDDK KD007169"],"award-info":[{"award-number":["NIDDK KD007169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["award326631"],"award-info":[{"award-number":["award326631"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["NIH NHLBI 2 R01 HL051387-18A1, 1P01HL108795-01"],"award-info":[{"award-number":["NIH NHLBI 2 R01 HL051387-18A1, 1P01HL108795-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>Pharmacological inhibition of PAI-1 augments proteolytic clearance of FGF23.<\/jats:p>","DOI":"10.1126\/sciadv.1603259","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T01:21:15Z","timestamp":1505352075000},"source":"Crossref","is-referenced-by-count":31,"title":["PAI-1 is a critical regulator of FGF23 homeostasis"],"prefix":"10.1126","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4482-9550","authenticated-orcid":false,"given":"Mesut","family":"Eren","sequence":"first","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."},{"name":"Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-6635","authenticated-orcid":false,"given":"Aaron T.","family":"Place","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."},{"name":"Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-4765","authenticated-orcid":false,"given":"Paul M.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Proteomics Center of Excellence, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Flevaris","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."},{"name":"Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Miyata","sequence":"additional","affiliation":[{"name":"United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-6613","authenticated-orcid":false,"given":"Douglas E.","family":"Vaughan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."},{"name":"Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh N.","year":"2004","unstructured":"N. Itoh, D. M. Ornitz, Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563\u2013569 (2004).","journal-title":"Trends Genet."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3528"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.02249-06"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul C.","year":"2011","unstructured":"C. Faul, A. P. Amaral, B. Oskouei, M.-C. Hu, A. Sloan, T. Isakova, O. M. Guti\u00e9rrez, R. Aguillon-Prada, J. Lincoln, J. M. Hare, P. Mundel, A. Morales, J. Scialla, M. Fischer, E. Z. Soliman, J. Chen, A. S. Go, S. E. Rosas, L. Nessel, R. R. Townsend, H. I. Feldman, M. St. John Sutton, A. Ojo, C. Gadegbeku, G. S. Di Marco, S. Reuter, D. Kentrup, K. Tiemann, M. Brand, J. A. Hill, O. W. Moe, M. Kuro-o, J. W. Kusek, M. G. Keane, M. Wolf, FGF23 induces left ventricular hypertrophy. J. Clin. Invest. 121, 4393\u20134408 (2011).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00064.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci M.","year":"2003","unstructured":"M. Riminucci, M. T. Collins, N. S. Fedarko, N. Cherman, A. Corsi, K. E. White, S. Waguespack, A. Gupta, T. Hannon, M. J. Econs, P. Bianco, P. Gehron Robey, FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J. Clin. Invest. 112, 683\u2013692 (2003).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pag\u00e8s A.","year":"2004","unstructured":"A. Benet-Pag\u00e8s, B. Lorenz-Depiereux, H. Zischka, K. E. White, M. J. Econs, T. M. Strom, FGF23 is processed by proprotein convertases but not by PHEX. Bone 35, 455\u2013462 (2004).","journal-title":"Bone"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1096\/fj.08-114397","article-title":"In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis","volume":"23","author":"Nakatani T.","year":"2009","unstructured":"T. Nakatani, B. Sarraj, M. Ohnishi, M. J. Densmore, T. Taguchi, R. Goetz, M. Mohammadi, B. Lanske, M. S. Razzaque, In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J. 23, 433\u2013441 (2009).","journal-title":"FASEB J."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11154-011-9199-8","article-title":"The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis","volume":"13","author":"Haussler M. R.","year":"2012","unstructured":"M. R. Haussler, G. K. Whitfield, I. Kaneko, R. Forster, R. Saini, J.-C. Hsieh, C. A. Haussler, P. W. Jurutka, The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis. Rev. Endocr. Metab. Disord. 13, 57\u201369 (2012).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: A possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu H. J.","year":"2009","unstructured":"H. J. Hsu, M.-S. Wu, Fibroblast growth factor 23: A possible cause of left ventricular hypertrophy in hemodialysis patients. Am. J. Med. Sci. 337, 116\u2013122 (2009).","journal-title":"Am. J. Med. Sci."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium, Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345\u2013348 (2000).","journal-title":"Nat. Genet."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05315"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jchf.2015.05.012","article-title":"Association of fibroblast growth factor-23 levels and angiotensin-converting enzyme inhibition in chronic systolic heart failure","volume":"3","author":"Wohlfahrt P.","year":"2015","unstructured":"P. Wohlfahrt, V. Melenovsky, M. Kotrc, J. Benes, A. Jabor, J. Franekova, S. Lemaire, J. Kautzner, P. Jarolim, Association of fibroblast growth factor-23 levels and angiotensin-converting enzyme inhibition in chronic systolic heart failure. JACC Heart Fail. 3, 829\u2013839 (2015).","journal-title":"JACC Heart Fail."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402218111"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/36285"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36699"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1073\/pnas.1321942111","article-title":"PAI-1\u2013regulated extracellular proteolysis governs senescence and survival in Klotho mice","volume":"111","author":"Eren M.","year":"2014","unstructured":"M. Eren, A. E. Boe, S. B. Murphy, A. T. Place, V. Nagpal, L. Morales-Nebreda, D. Urich, S. E. Quaggin, G. R. S. Budinger, G. M. Mutlu, T. Miyata, D. E. Vaughan, PAI-1\u2013regulated extracellular proteolysis governs senescence and survival in Klotho mice. Proc. Natl. Acad. Sci. U.S.A. 111, 7090\u20137095 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2215\/CJN.07290714","article-title":"Biomarkers of kidney injury and Klotho in patients with atherosclerotic renovascular disease","volume":"10","author":"Park M. Y.","year":"2015","unstructured":"M. Y. Park, S. M. Herrmann, A. Saad, A. Eirin, H. Tang, A. Lerman, S. C. Textor, L. O. Lerman, Biomarkers of kidney injury and Klotho in patients with atherosclerotic renovascular disease. Clin. J. Am. Soc. Nephrol. 10, 443\u2013451 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1681\/ASN.2006050503","article-title":"Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action","volume":"17","author":"Eddy A. A.","year":"2006","unstructured":"A. A. Eddy, A. B. Fogo, Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action. J. Am. Soc. Nephrol. 17, 2999\u20133012 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"18C","DOI":"10.1016\/S0002-9149(01)01509-0","article-title":"Angiotensin, fibrinolysis, and vascular homeostasis","volume":"87","author":"Vaughan D. E.","year":"2001","unstructured":"D. E. Vaughan, Angiotensin, fibrinolysis, and vascular homeostasis. Am. J. Cardiol. 87, 18C\u201324C (2001).","journal-title":"Am. J. Cardiol."},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1538-7836.2011.04278.x","article-title":"Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis","volume":"9","author":"Gebbink M. F. B. G.","year":"2011","unstructured":"M. F. B. G. Gebbink, Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis. J. Thromb. Haemost. 9 (suppl. 1), 174\u2013181 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.113.006727","article-title":"Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy","volume":"129","author":"Tersteeg C.","year":"2014","unstructured":"C. Tersteeg, S. de Maat, S. F. De Meyer, M. W. J. Smeets, A. D. Barendrecht, M. Roest, G. Pasterkamp, R. Fijnheer, K. Vanhoorelbeke, P. G. de Groot, C. Maas, Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Circulation 129, 1320\u20131331 (2014).","journal-title":"Circulation"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2001.tb03511.x","article-title":"Elements of the fibrinolytic system","volume":"936","author":"Lijnen H. R.","year":"2001","unstructured":"H. R. Lijnen, Elements of the fibrinolytic system. Ann. N. Y. Acad. Sci. 936, 226\u2013236 (2001).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1448"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"12052","DOI":"10.1073\/pnas.1120437109","article-title":"Plasminogen activator inhibitor 1-insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence","volume":"109","author":"Elzi D. J.","year":"2012","unstructured":"D. J. Elzi, Y. Lai, M. Song, K. Hakala, S. T. Weintraub, Y. Shiio, Plasminogen activator inhibitor 1-insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence. Proc. Natl. Acad. Sci. U.S.A. 109, 12052\u201312057 (2012).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.826"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf M.","year":"2011","unstructured":"M. Wolf, M. Z. Molnar, A. P. Amaral, M. E. Czira, A. Rudas, A. Ujszaszi, I. Kiss, L. Rosivall, J. Kosa, P. Lakatos, C. P. Kovesdy, I. Mucsi, Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J. Am. Soc. Nephrol. 22, 956\u2013966 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.0000023186.60090.FB","article-title":"Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1","volume":"106","author":"Eren M.","year":"2002","unstructured":"M. Eren, C. A. Painter, J. B. Atkinson, P. J. Declerck, D. E. Vaughan, Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation 106, 491\u2013496 (2002).","journal-title":"Circulation"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2007.02587.x","article-title":"Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice","volume":"5","author":"Eren M.","year":"2007","unstructured":"M. Eren, L. A. Gleaves, J. B. Atkinson, L. E. King, P. J. Declerck, D. E. Vaughan, Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice. J. Thromb. Haemost. 5, 1500\u20131508 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2215\/CJN.00550112","article-title":"FGF-23 levels in patients with AKI and risk of adverse outcomes","volume":"7","author":"Leaf D. E.","year":"2012","unstructured":"D. E. Leaf, M. Wolf, S. S. Waikar, H. Chase, M. Christov, S. Cremers, L. Stern, FGF-23 levels in patients with AKI and risk of adverse outcomes. Clin. J. Am. Soc. Nephrol. 7, 1217\u20131223 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2110-5820-1-21","article-title":"FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study","volume":"1","author":"Zhang M.","year":"2011","unstructured":"M. Zhang, R. Hsu, C.-y. Hsu, K. Kordesch, E. Nicasio, A. Cortez, I. McAlpine, S. Brady, H. Zhuo, K. N. Kangelaris, J. Stein, C. S. Calfee, K. D. Liu, FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study. Ann. Intensive Care 1, 21 (2011).","journal-title":"Ann. Intensive Care"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ki.2008.179","article-title":"Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury","volume":"74","author":"Long D. A.","year":"2008","unstructured":"D. A. Long, K. L. Price, E. Ioffe, C. M. Gannon, L. Gnudi, K. E. White, G. D. Yancopoulos, J. S. Rudge, A. S. Woolf, Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int. 74, 300\u2013309 (2008).","journal-title":"Kidney Int."},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury","volume":"84","author":"Christov M.","year":"2013","unstructured":"M. Christov, S. S. Waikar, R. C. Pereira, A. Havasi, D. E. Leaf, D. Goltzman, P. D. Pajevic, M. Wolf, H. J\u00fcppner, Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int. 84, 776\u2013785 (2013).","journal-title":"Kidney Int."},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/gerona\/glp005","article-title":"Association between inflammatory components and physical function in the health, aging, and body composition study: A principal component analysis approach","volume":"64","author":"Hsu F.-C.","year":"2009","unstructured":"F.-C. Hsu, S. B. Kritchevsky, Y. Liu, A. Kanaya, A. B. Newman, S. E. Perry, M. Visser, M. Pahor, T. B. Harris, B. J. Nicklas; Health ABC Study, Association between inflammatory components and physical function in the health, aging, and body composition study: A principal component analysis approach. J. Gerontol. A Biol. Sci. Med. Sci. 64, 581\u2013589 (2009).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.psyneuen.2012.02.006","article-title":"Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney memory and aging study","volume":"37","author":"Baune B. T.","year":"2012","unstructured":"B. T. Baune, E. Smith, S. Reppermund, T. Air, K. Samaras, O. Lux, H. Brodaty, P. Sachdev, J. N. Trollor, Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney memory and aging study. Psychoneuroendocrinology 37, 1521\u20131530 (2012).","journal-title":"Psychoneuroendocrinology"},{"key":"e_1_3_1_37_2","first-page":"4323","article-title":"Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen activator","volume":"273","author":"Coombs G. S.","year":"1998","unstructured":"G. S. Coombs, R. C. Bergstrom, E. L. Madison, D. R. Corey, Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen activator. J. Biol. Chem. 273, 4323\u20134328 (1998).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11154-015-9318-z","article-title":"The PTH-vitamin D-FGF23 axis","volume":"16","author":"Blau J. E.","year":"2015","unstructured":"J. E. Blau, M. T. Collins, The PTH-vitamin D-FGF23 axis. Rev. Endocr. Metab. Disord. 16, 165\u2013174 (2015).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato K.","year":"2006","unstructured":"K. Kato, C. Jeanneau, M. A. Tarp, A. Benet-Pag\u00e8s, B. Lorenz-Depiereux, E. P. Bennett, U. Mandel, T. M. Strom, H. Clausen, Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370\u201318377 (2006).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.2354","article-title":"FGF23 is endogenously phosphorylated in bone cells","volume":"30","author":"Lindberg I.","year":"2015","unstructured":"I. Lindberg, H. W. Pang, J. P. Stains, D. Clark, A. J. Yang, L. Bonewald, K. Z. Li, FGF23 is endogenously phosphorylated in bone cells. J. Bone Miner. Res. 30, 449\u2013454 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.transproceed.2006.03.059","article-title":"Chronic kidney disease is still present after renal transplantation with excellent function","volume":"38","author":"Bertoni E.","year":"2006","unstructured":"E. Bertoni, A. Rosati, A. Larti, C. Merciai, M. Zanazzi, G. Rosso, M. Gallo, R. Marcucci, M. Salvadori, Chronic kidney disease is still present after renal transplantation with excellent function. Transplant. Proc. 38, 1024\u20131025 (2006).","journal-title":"Transplant. Proc."},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00467-014-2997-y","article-title":"Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease","volume":"30","author":"Makulska I.","year":"2015","unstructured":"I. Makulska, M. Szczepa\u0144ska , D. Dro\u017cd\u017c, D. Polak-Jonkisz, D. Zwoli\u0144ska, Skin autofluorescence as a novel marker of vascular damage in children and adolescents with chronic kidney disease. Pediatr. Nephrol. 30, 811\u2013819 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.numecd.2009.01.011","article-title":"Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status","volume":"20","author":"Norata G. D.","year":"2010","unstructured":"G. D. Norata, I. Baragetti, S. Raselli, A. Stucchi, K. Garlaschelli, S. Vettoretti, G. Piloni, G. Buccianti, A. L. Catapano, Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status. Nutr. Metab. Cardiovasc. Dis. 20, 56\u201363 (2010).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1242\/jcs.079889","article-title":"Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase","volume":"124","author":"Bernot D.","year":"2011","unstructured":"D. Bernot, J. Stalin, P. Stocker, B. Bonardo, I. Scroyen, M.-C. Alessi, F. Peiretti, Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase. J. Cell Sci. 124, 1224\u20131230 (2011).","journal-title":"J. Cell Sci."},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/eurheartj\/ehm605","article-title":"Left ventricular mass predicts heart failure not related to previous myocardial infarction: The Cardiovascular Health Study","volume":"29","author":"de Simone G.","year":"2008","unstructured":"G. de Simone, J. S. Gottdiener, M. Chinali, M. S. Maurer, Left ventricular mass predicts heart failure not related to previous myocardial infarction: The Cardiovascular Health Study. Eur. Heart J. 29, 741\u2013747 (2008).","journal-title":"Eur. Heart J."},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong W. H.","year":"2013","unstructured":"W. H. Chong, P. Andreopoulou, C. C. Chen, J. Reynolds, L. Guthrie, M. Kelly, R. I. Gafni, N. Bhattacharyya, A. M. Boyce, D. El-Maouche, D. O. Crespo, R. Sherry, R. Chang, F. M. Wodajo, G. B. Kletter, A. Dwyer, M. T. Collins, Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J. Bone Miner. Res. 28, 1386\u20131398 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00223-009-9216-z","article-title":"Effects of tumor-induced osteomalacia on the bone mineralization process","volume":"84","author":"Nawrot-Wawrzyniak K.","year":"2009","unstructured":"K. Nawrot-Wawrzyniak, F. Varga, A. Nader, P. Roschger, S. Sieghart, E. Zwettler, K. M. Roetzer, S. Lang, R. Weinkamer, K. Klaushofer, N. Fratzl-Zelman, Effects of tumor-induced osteomalacia on the bone mineralization process. Calcif. Tissue Int. 84, 313\u2013323 (2009).","journal-title":"Calcif. Tissue Int."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13000-016-0477-3","article-title":"Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant","volume":"11","author":"Shiba E.","year":"2016","unstructured":"E. Shiba, A. Matsuyama, R. Shibuya, K. Yabuki, H. Harada, M. Nakamoto, T. Kasai, M. Hisaoka, Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant. Diagn. Pathol. 11, 26 (2016).","journal-title":"Diagn. Pathol."},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(84)90782-6"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/pmic.201300438","article-title":"The first pilot project of the consortium for top-down proteomics: A status report","volume":"14","author":"Dang X.","year":"2014","unstructured":"X. Dang, J. Scotcher, S. Wu, R. K. Chu, N. Toli\u0107, I. Ntai, P. M. Thomas, R. T. Fellers, B. P. Early, Y. Zheng, K. R. Durbin, R. D. Leduc, J. J. Wolff, C. J. Thompson, J. Pan, J. Han, J. B. Shaw, J. P. Salisbury, M. Easterling, C. H. Borchers, J. S. Brodbelt, J. N. Agar, L. Pa\u0161a-Toli\u0107, N. L. Kelleher, N. L. Young, The first pilot project of the consortium for top-down proteomics: A status report. Proteomics 14, 1130\u20131140 (2014).","journal-title":"Proteomics"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.1603259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:38:20Z","timestamp":1704821900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.1603259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1126\/sciadv.1603259"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.1603259","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]},"article-number":"e1603259"}}